Search results
CDI is defined by the presence of symptoms (usually diarrhea) and either a stool test positive for C. difficile toxins or detection of toxigenic C. difficile, or colonoscopic or histopathologic findings revealing pseudomembranous colitis. In addition to diagnosis and management, recommended methods of infection control and environmental ...
- Guideline Development Process
Guideline Panelists; Clinical Practice Guidelines...
- Ebola
Symptoms can occur abruptly and include fever, severe...
- Bio-Preparedness Workforce Pilot
On Thursday, June 15, in Washington, D.C., Axios health care...
- Evaluation and Management Services
Dr. Timothy Sullivan, Vice Chair of IDSA’s Coding & Payment...
- Infection Prevention & Control
IDSA/SHEA: Primer on Healthcare Epidemiology, Infection...
- Governance
Governance of IDSA; idsa committees; idsa bylaws. This...
- Privacy Policy
The Infectious Diseases Society of America (“IDSA”) respects...
- Terms of Use
Please note that, pursuant to 17 U.S.C. § 512(f), any...
- Guideline Development Process
4 sty 2024 · If you keep an eye on your feces, you may be able to see changes and get treatment for C. diff right away. The Bristol Stool Chart displays the spectrum of stool consistency, from hard and dense to soft and watery.
1 lut 2020 · C. difficile infection is characterized by a wide range of symptoms, from mild or moderate diarrhea to severe disease with pseudomembranous colitis, colonic ileus, toxic megacolon, sepsis, or...
The increasing incidence and recurrence rates of CDI together with its associated morbidity and mortality are great concerns. Newer treatment methods, such as narrow-spectrum antibiotics, monoclonal antibodies, and microbial replacement therapies, are being developed and implemented.
19 mar 2024 · The treatment of CDI in adults, including management of initial disease, recurrent disease, severe disease, and fulminant disease (previously referred to as severe, complicated CDI) will be reviewed here [4]. Issues related to surgical management of CDI are discussed separately.
18 sie 2020 · Clostridioides difficile (formerly Clostridium difficile also known as C. difficile or C. diff) is an anaerobic Gram-positive spore forming bacterium that is ubiquitous in our environment [5].
14 cze 2021 · This clinical practice guideline is a focused update on management of Clostridioides difficile infection (CDI) in adults specifically addressing the use of fidaxomicin and bezlotoxumab for the treatment of CDI.
